UnitedHealth Group (NYSE:UNH) Price Target Raised to $460.00

UnitedHealth Group (NYSE:UNH) had its target price increased by analysts at Mizuho from $440.00 to $460.00 in a research report issued on Monday,Benzinga reports. The firm currently has an “outperform” rating on the healthcare conglomerate’s stock. Mizuho’s price objective indicates a potential upside of 13.88% from the company’s current price.

A number of other equities research analysts have also recently commented on the company. UBS Group upped their target price on shares of UnitedHealth Group from $410.00 to $460.00 and gave the company a “buy” rating in a report on Friday, May 22nd. Sanford C. Bernstein increased their price objective on UnitedHealth Group from $444.00 to $492.00 and gave the stock an “outperform” rating in a report on Wednesday, May 27th. Leerink Partners lifted their price objective on shares of UnitedHealth Group from $345.00 to $400.00 and gave the company an “outperform” rating in a research note on Wednesday, April 22nd. Royal Bank Of Canada boosted their target price on shares of UnitedHealth Group from $361.00 to $400.00 and gave the company an “outperform” rating in a research report on Wednesday, April 22nd. Finally, Oppenheimer boosted their price objective on shares of UnitedHealth Group from $385.00 to $405.00 and gave the stock an “outperform” rating in a report on Wednesday, April 22nd. One analyst has rated the stock with a Strong Buy rating, twenty have issued a Buy rating, five have given a Hold rating and one has assigned a Sell rating to the stock. Based on data from MarketBeat, the company has a consensus rating of “Moderate Buy” and a consensus target price of $407.17.

UnitedHealth Group Stock Performance

UnitedHealth Group stock traded up $4.46 during mid-day trading on Monday, hitting $403.93. The company had a trading volume of 2,978,085 shares, compared to its average volume of 8,944,235. The company has a current ratio of 0.80, a quick ratio of 0.80 and a debt-to-equity ratio of 0.69. The company’s fifty day moving average is $348.12 and its 200-day moving average is $323.61. UnitedHealth Group has a 12-month low of $234.60 and a 12-month high of $405.72. The company has a market capitalization of $366.83 billion, a price-to-earnings ratio of 30.50, a P/E/G ratio of 1.61 and a beta of 0.64.

UnitedHealth Group (NYSE:UNH) last posted its quarterly earnings data on Tuesday, April 21st. The healthcare conglomerate reported $7.23 earnings per share (EPS) for the quarter, beating the consensus estimate of $6.76 by $0.47. The firm had revenue of $111.65 billion for the quarter, compared to the consensus estimate of $109.84 billion. UnitedHealth Group had a return on equity of 14.65% and a net margin of 2.68%.The company’s quarterly revenue was up 2.0% compared to the same quarter last year. During the same quarter in the previous year, the business earned $7.20 EPS. UnitedHealth Group has set its FY 2026 guidance at 18.250- EPS. Equities research analysts predict that UnitedHealth Group will post 18.32 EPS for the current year.

Insider Buying and Selling at UnitedHealth Group

In other UnitedHealth Group news, CEO Patrick Hugh Conway sold 800 shares of the company’s stock in a transaction dated Thursday, April 23rd. The shares were sold at an average price of $355.00, for a total transaction of $284,000.00. Following the transaction, the chief executive officer directly owned 17,805 shares in the company, valued at approximately $6,320,775. This represents a 4.30% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which can be accessed through this link. 0.28% of the stock is currently owned by company insiders.

Hedge Funds Weigh In On UnitedHealth Group

Institutional investors and hedge funds have recently added to or reduced their stakes in the company. Sarver Vrooman Wealth Advisors bought a new position in UnitedHealth Group during the fourth quarter worth $25,000. Beacon Financial Strategies CORP acquired a new position in shares of UnitedHealth Group in the 4th quarter valued at $26,000. Anfield Capital Management LLC increased its position in shares of UnitedHealth Group by 220.0% during the fourth quarter. Anfield Capital Management LLC now owns 80 shares of the healthcare conglomerate’s stock worth $26,000 after acquiring an additional 55 shares in the last quarter. Joseph Group Capital Management acquired a new position in UnitedHealth Group in the 4th quarter worth $27,000. Finally, Nalls Sherbakoff Group LLC bought a new stake in shares of UnitedHealth Group in the fourth quarter valued at about $27,000. 87.86% of the stock is owned by hedge funds and other institutional investors.

UnitedHealth Group Company Profile

UnitedHealth Group Inc is a diversified health care company headquartered in Minnetonka, Minnesota, that operates two primary business platforms: UnitedHealthcare and Optum. Founded in 1977, the company provides a broad range of health benefits and health care services to individuals, employers, governmental entities and other organizations. Its operations span commercial employer-sponsored plans, individual and Medicare and Medicaid programs, and services for customers and health systems in the United States and selected international markets.

UnitedHealthcare is the company’s benefits business, administering health plans and networks, managing provider relationships, and offering coverage products for employers, individuals, and government-sponsored programs.